Cite
APA Citation
Kintu, K., Malaba, T. R., Nakibuka, J., Papamichael, C., Colbers, A., Byrne, K., Seden, K., Hodel, E. M., Chen, T., Twimukye, A., Byamugisha, J., Reynolds, H., Watson, V., Burger, D., Wang, D., Waitt, C., Taegtmeyer, M., Orrell, C., Lamorde, M., Myer, L., Khoo, S., & , (2020). dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial. Lancet, 7(5), e332–e339. http://access.bl.uk/ark:/81055/vdc_100104117017.0x000006